Table 3.

Monitoring of antiviral therapy

Fortnightly:	CBC at weeks 1, 2, 4, 6, 8 and then monthly
Week 4:	Qualitative HCV RNA assay at week 4 in both genotype 1 and ‘2 and 3’ cases to assess for RVR
Week 12:	Qualitative HCV RNA assay at week 12 in genotype 2 or 3 cases only to assess for EVR
Every 3 months:	LFTs, creatinine, glucose and TSH
Week 24:	Qualitative HCV RNA assay at week 24 in only those genotype 1 cases wherein EVR is attained at week 12
Week 48:	Qualitative HCV RNA assay at week 48 in genotype ‘2 and 3’ cases to determine SVR
	Qualitative HCV RNA assay at week 48 in genotype 1 cases to determine ETR
Week 72:	Qualitative HCV RNA assay at week 72 in genotype 1 cases to determine SVR